PW
VRTX icon

PUREfi Wealth’s Vertex Pharmaceuticals VRTX Stock Holding History

PUREfi Wealth’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$772K Buy
1,477
+294
+25% +$151K 0.36% 67
2026
Q2 		$588K Buy
1,183
+30
+3% +$13.3K 0.32% 72
2026
Q1 		$515K Buy
1,153
+336
+41% +$157K 0.34% 73
2025
Q4 		$370K Sell
817
-126
-13% -$54.3K 0.28% 95
2025
Q3 		$369K Buy
943
+7
+0.7% +$2.92K 0.28% 102
2025
Q2 		$417K Buy
936
+42
+5% +$19.4K 0.33% 81
2025
Q1 		$433K Buy
894
+383
+75% +$178K 0.43% 65
2024
Q4 		$206K Buy
+511
New +$237K 0.2% 145

Other funds holding VRTX

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return
Davenport & Co
Davenport & Co Richmond, Virginia $19.9B AUM 12.67% 1-Year Est. Return
Montrusco Bolton Investments
Montrusco Bolton Investments Montreal, Quebec, Canada $5.77B AUM 24.61% 1-Year Est. Return
Birch Hill Investment Advisors
Birch Hill Investment Advisors Boston, Massachusetts $2.43B AUM 15.45% 1-Year Est. Return
Fjarde Ap-fonden
Fjarde Ap-fonden Stockholm, Sweden $19.4B AUM 31.69% 1-Year Est. Return
Vontobel Holding
Vontobel Holding Zurich, Switzerland $27.7B AUM 21.75% 1-Year Est. Return
MN Services Vermogensbeheer
MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return
Czech National Bank
Czech National Bank Prague, Czech Republic $18.9B AUM 36.24% 1-Year Est. Return
AMI Asset Management
AMI Asset Management Los Angeles, California $1.74B AUM 24.77% 1-Year Est. Return

PUREfi Wealth's VRTX Position: Q3 2026 in Review

PUREfi Wealth increased its Vertex Pharmaceuticals (VRTX) stake by 25% in Q3 2026, buying an estimated $151K and bringing the position to 1,477 shares worth $772K. The position accounts for 0.36% of the portfolio, ranked #67.

PUREfi Wealth first reported a position in VRTX in Q4 2024 and has held it in 8 quarters since. 346 funds tracked by Wall St. Rank hold VRTX as of Q3 2026.

  • PUREfi Wealth held 1,477 shares of Vertex Pharmaceuticals worth $772K as of Q3 2026.
  • PUREfi Wealth bought 294 Vertex Pharmaceuticals shares in Q3 2026, an estimated $151K.
  • Vertex Pharmaceuticals made up 0.36% of PUREfi Wealth's portfolio in Q3 2026, its #67 holding.
  • PUREfi Wealth first reported a position in Vertex Pharmaceuticals in Q4 2024 and has held it in 8 quarters since.
  • 346 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2026.

Based on PUREfi Wealth's 13F filing for Q3 2026, filed 19 Oct 2026.